No benefit seen from adjuvant celecoxib in ERBB2-negative breast cancer
(HealthDay)—For patients with ERBB2-negative breast cancer, two years of treatment with celecoxib ...
Daily e-cigarette use shows ‘clear benefit’ in helping smokers to quit
A new study published Tuesday 10 March, No Smoking...
Imaging identifies breast cancer patients unlikely to benefit from hormone therapy
Hormone therapy commonly is given as a targeted tr...
Curbing COVID Brought Unexpected Benefit for Asthma Patients
TUESDAY, Oct. 20, 2020 — Measures enacted to...
Tailored education system to benefit kidney transplant patients
Patients with chronic kidney disease and end-stage...
Children with asthma could benefit from prescribing according to genetic differences
Selecting treatments according to genetic differen...
Immunotherapy biomarker discovery could benefit thousands with Type 1 diabetes
Scientists at UCL have discovered new biomarkers, ...
Diabetic nephropathy: Study results on proteomic analysis do not show benefit
One of the consequences of diabetes mellitus, part...
One-week course of radiotherapy could benefit women with early stage breast cancer, study finds
A one-week course of radiotherapy in fewer but lar...
Beyond child’s play, hula-hooping can benefit your health and fitness
In a bid to get fit, it helps to think outside the...